Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002235164 | SCV001007069 | likely benign | Ehlers-Danlos syndrome, classic type, 1 | 2023-10-28 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV003227873 | SCV003924173 | likely benign | Ehlers-Danlos syndrome, classic type, 2 | 2021-03-30 | criteria provided, single submitter | clinical testing | COL5A2 NM_000393.4 exon 13 c.906+9A>G: This variant has not been reported in the literature but is present in 0.01% (8/41404) of African alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/2-189080981-T-C?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:698570). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. Although this variant occurs in the splice region, computational prediction tools do not suggest that it alters splicing. However, further studies are needed to understand its impact. In summary, data on this variant suggests that this variant does not cause disease, but requires further evidence. Therefore this variant is classified as likely benign. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003323747 | SCV004028667 | benign | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003918377 | SCV004727834 | likely benign | COL5A2-related disorder | 2020-06-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |